Rheumatology (Oxford, England)
Neutrophil-to-lymphocyte ratio as a biomarker for disease onset and mortality risk in systemic sclerosis: a real-world national cohort study.
Shiri Keret, Shlomit Yaari, Aniela Shouval, Alaa Sawaed, Noa Nemesh, Lisa Kaly, Abid Awisat, Itzhak Rosner, Michael Rozenbaum, Nina Boulman, Emilia Hardak, Gleb Slobodin, Doron Rimar
Published: 202510.1093/rheumatology/keaf664
Abstract
OBJECTIVES: Elevated neutrophil-to-lymphocyte ratio (NLR)≥2.95 has been linked to adverse outcomes in systemic sclerosis (SSc). This study aimed to determine whether elevated NLR can signal disease onset, identify NLR threshold predictive of poor pro…
Preview only. Read the full abstract at the source